Creative Biolabs Service
Creative Biolabs provides Cell-SELEX within our aptamer discovery services for projects that need aptamers selected against intact cells. We design positive and counter-cell selection around the phenotype, cell state, background, and specificity question. This route keeps the target surface in a cellular context and supports candidate evaluation at the cell level.
Cell aptamer selection uses intact cells as the selection target so surface features remain in a biological membrane context. The route is useful when the desired recognition pattern is defined at the cell level or when a single purified protein is not the right selection surrogate. Positive and counter cells, cell state, culture conditions, handling, and phenotype stability all influence the selection question.
Define the target cell type, relevant phenotype, culture state, passage or preparation constraints, and the feature that should be recognized.
Choose biologically relevant negative cells that represent the background or off-target population the aptamer should avoid.
Culture, viability, dissociation, incubation, washing, and storage conditions should preserve the phenotype used for selection.
Intended cell-level readout, specificity goal, and downstream research use guide candidate evaluation after enrichment.
Add additional cell populations when broader cell-level discrimination is needed.
Extend evaluation beyond the discovery screen when more detailed binding evidence is required.
Refine selected sequences for a defined downstream research need.
Plan additional cell-based research assays when candidate behavior must be tested in a specific biological context.
The positive and counter populations should differ in a way that matches the desired recognition question. A closely related counter cell can be more informative than an unrelated cell because it removes binders to shared surface features.
Cell surfaces change with culture conditions, activation state, density, dissociation method, and handling. We review which conditions must stay consistent so selection pressure is directed at the intended phenotype instead of a handling artifact.
Cells present many abundant surface and matrix features. Background pressure can be applied through counter cells, blocking conditions, or other agreed controls so broadly adhesive sequences do not dominate the pool.
Bound and unbound sequences must be separated without changing the cell state more than necessary. Selection pressure can be increased as the pool evolves, but overly aggressive conditions early in the process may remove useful diversity.
If the project is centered on one known protein and the main issue is preserving its native presentation, Native-Context Protein Aptamer Selection may be the clearer route. Whole-cell selection is better when the recognition question is defined by a cell phenotype, composite surface signature, or cell-level discrimination problem.
Confirm positive cells, counter cells, phenotype, culture conditions, handling limits, and the intended cell-level specificity question.
Prepare positive and counter populations under matched conditions and define how bound and unbound sequences will be separated.
Run repeated positive and counter-selection cycles while maintaining the cell state required by the project.
Track target-versus-counter behavior and adjust selection pressure when broad cell binding or background becomes dominant.
Identify candidate sequences and compare binding to the intended positive cell population.
Evaluate key counter cells or cell panels in the agreed scope and prepare the candidate and data package for downstream work.
Positive and counter cells are defined around the biological recognition question, not only cell names.
Counter populations can be chosen to remove binding to shared surface features and common background.
Culture and handling conditions are considered because phenotype drift can change what the library sees during selection.
Candidate behavior is interpreted against positive and counter cells rather than pool enrichment alone.
Cell-binding aptamers can support research that requires selective recognition, capture, or profiling of cell populations.
Whole-cell selection can be used when the useful recognition pattern is defined by a cell phenotype rather than one purified target.
Tumor and non-tumor cell comparisons can provide a defined cell-level specificity question for research selection programs.
Cell-selective aptamers can be evaluated for downstream labeling or delivery research after binding specificity is established.
Earnest and colleagues reported a 2021 whole-cell SELEX study using MLL-AF9-expressing AML cells as the positive target and fibroblast cells as counter cells.1 The schematic shows how cell-level counter selection was placed inside the iterative selection process. After enrichment, the authors used high-throughput sequencing to identify candidates and flow cytometry to compare binding to target and non-target cell populations. This is one disease-model study and it illustrates a broader design principle: counter-cell choice should be connected to the intended specificity question, and candidate specificity still needs direct cell-level testing after pool enrichment.
Cell-SELEX uses intact cells as selection targets so the library encounters cell-surface features in a membrane context. Positive and counter cells are used to shape cell-level specificity.
Choose populations that reflect the actual recognition problem. Closely related cells are often useful when the goal is to remove binding to shared surface features.
Yes. Cell state, passage, activation, dissociation, and handling can change the surface phenotype. Conditions should be controlled well enough to keep the selection question stable.
Use native-context protein selection when one known protein is the target and the main issue is preserving its native presentation. Use whole-cell selection when the desired recognition pattern is defined at the cell level.
Yes, when a broader cell panel is included in scope. The panel should be selected around the most important specificity risks.
Candidates can move into cell-binding and specificity evaluation, characterization, optimization, or another downstream research assay as needed.
Share the positive cell population, counter cells, culture context, and desired cell-level specificity. Creative Biolabs can help define a focused Cell-SELEX project.
